What question did this study set out to answer?

June 13, 2026Neurology

Observational Study of Inebilizumab as a Salvage Therapy for Acute Optic Neuritis in Neuromyelitis Optica Spectrum Disorder (NMOSD-ON) (P4-1.001)

View Full Paper

Ask AI

Bookmark

Authors

Observational study assesses inebilizumab efficacy as salvage therapy in acute NMOSD-ON, suggesting a role in treatment strategy.

The research aims to evaluate the effectiveness and safety of inebilizumab as a salvage therapy for acute optic neuritis in NMOSD when corticosteroids are ineffective.
Conducted an observational study to assess inebilizumab's performance as a salvage therapy.
Focused on patients with acute optic neuritis related to neuromyelitis optica spectrum disorder.
Monitored efficacy and safety endpoints after inebilizumab administration.
Inebilizumab showed promising efficacy in resolving symptoms of acute optic neuritis.
Safety profile indicates acceptable tolerance among patients after treatment.
Potentially supports the use of inebilizumab as a first-line therapy in future treatment protocols.

Yang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark